Intellectual Property Watch was an independent newspaper that covered international IP policy from 2005-2019
Explore its archives with the menu or the link below.
Latest articles
Trump Highlights IP, Trade, Drug Prices In Speech To Congress
President Donald Trump gave the US Congress a rosy, nationalistic presentation of the condition of the US economy and security last night and amid the range of issues raised, mentioned…
US IP Enforcement Coordinator Under Trump Asks, “What Can We Do Differently?”
The Trump administration is taking the US intellectual property enforcement coordinator’s role in new directions, building on past administrations but trying to address ways it has not been effective in…
TRIPS Debated As WHO Board Reaches Agreement On Universal Health Coverage
World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall,…
WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA
The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating…
WHO Governance Questioned As It Adds World Health Assembly Agenda Item On Biodiversity
The World Health Organization today admitted to an unusual procedure to set up a debate on the health implications of a UN treaty on sharing of benefits from genetic resources.…
Latest articles
Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues
Shortages, faulty supply chains, unbearable prices, weak health systems – the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Or…
Read More
WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing
A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspe…
Read More
WHO Holds Discussions On Roadmap For Improving Access To Medicines
Unaffordable prices, unavailable medicines, a rising need for accessible noncommunicable diseases treatments – these set the stage as the World Health Organization Executive Board started discussion t…
Read MoreDNDi, MMV Make 400 Compounds Available To Boost Pandemic Disease Research
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) today announced the launch of the "Pandemic Response Box", which offers researchers open access to 400 compou…
Read More
Measuring Outputs Seen As Key To WHO Transformation
Measurable outputs are a key element of the World Health Organization transformation and its “triple billion” target. Last week, WHO Executive Board discussed the Impact Framework, a key measurement s…
Read More
WHO Draft Resolution On Universal Health Coverage Shows Efforts At Consensus
With half the world’s population still lacking access to essential health services, World Health Organization Executive Board members this week are working to agree on a resolution indicating ways thr…
Read More